Mid-Week Coffee Break - P&L Scientific Inc.

Virtual technology talk between IVAM Members
Apr 15, 2026, 9:00 a.m. - 10:00 a.m.
members-only virtual
Zoom Meeting

Curious about new technologies and fresh impulses from the IVAM network?

The Mid-Week Coffee Break brings IVAM members together online every four weeks to explore new ideas, share perspectives, and build connections within the network.

Each session starts with a short, inspiring impulse from the IVAM network, followed by open exchange, questions, discussion, and personal networking.

We meet regularly on the third Wednesday of each month — easy to join, engaging, and focused on what really matters: people, ideas, and meaningful exchange.

IVAM warmly invites you to the next Mid-Week Coffee Break:

🗓 April 15, 2026
🕘 09:00–10:00 a.m. (CET)
💻 Online via Zoom

This time, we are especially pleased to welcome P&L Scientific Inc. as our host.
In a compact impulse talk, Mr. Jun Peng will share insights into:

„Overview and Market Entry of US Healthcare Devices Market"

 

Look forward to practical insights, fresh perspectives, and direct exchange with fellow IVAM members.

👉 Participation is free of charge for IVAM members — registration via the ticket shop.  

 

Interested in hosting a future Mid-Week Coffee Break or bringing your own topic to the IVAM community?
Feel free to get in touch at membership@ivam.de!

Speakers


Your Contact

Alice Kasjanow
Membership Relations Manager
+49 (0) 231 9742 168

Further events

Mar 18, 2026, 9:00 a.m. - 10:00 a.m.
Virtual technology talk between IVAM Members
May 20, 2026, 9:00 a.m. - 10:00 a.m.
Virtual technology talk between IVAM Members
Mar 3 - 5, 2027
Discover the Future of Photonics with IVAM

Recommended news

Apr 1, 2025

The technical program for the IVAM Hightech Summit 2025, taking place on May 21–22 at Signal Iduna Park in …

Feb 17, 2026

Autonomous systems, robotics and high-tech components take center stage: At XPONENTIAL Europe 2026 in March, IVAM will for the first …

Feb 15, 2026

CorTec has completed the second successful implantation of its fully implantable brain-computer interface system as part of an FDA-approved clinical …